Bahrain is actively participating in the UAE's phase III clinical trials for the COVID-19 vaccine.
According to Ashish Koshy, the CEO of G42 Healthcare, Bahrain is working on enrolling and vaccinating close to 6,000 volunteers.
He clarified that this expansion enforces the ongoing collaboration between the two countries.
Speaking to ARN News, Koshy revealed that there will be more collaborations in the future.
He explained that the current trials have also shown positive results so far.
UAE launches world's first fully integrated AI-powered judicial platform
UAE President and Greek Prime Minister discuss boosting trade ties
ERC's 'Water Aid' initiative to reduce impact of extreme weather in UAE, abroad
Dubai Police blocks over 290 websites for promoting drugs
UAE fines 42 domestic worker recruitment firms for violating rules
